Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer (BRCA) characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression (Aysola et al., 2013). This evidence concerns the gene PGR and invasive breast carcinoma.